Neuland Laboratories announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2025. Revenue from operations stood at ₹514.27 million for the quarter. The company reported a profit of ₹96.85 million for the same period. The Board of Directors approved these results at a meeting held on November 7, 2025.
Financial Performance Highlights
Neuland Laboratories has released its unaudited consolidated financial results, offering insights into its performance for the second quarter (Q2) of fiscal year 2026.
Key Financial Figures (Consolidated)
- Revenue from operations:₹514.27 million for Q2 FY26 compared to ₹310.84 million for Q2 FY25.
- Total Income:₹516.07 million for Q2 FY26.
- Profit after tax:₹96.85 million for Q2 FY26 compared to ₹32.84 million for Q2 FY25.
- Earnings Per Share: stands at ₹75.49.
Half-Year Performance
The cumulative figures for the half-year ended September 30, 2025, indicate the following:
- Revenue from operations:₹807.03 million
- Profit after tax:₹110.75 million
Auditor’s Review
The results were reviewed by MSKA & Associates, Chartered Accountants, whose review report expressed an unmodified opinion.
Source: BSE
